These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35004610)

  • 1. Therapeutic Effect of Novel Cyanopyrrolidine-Based Prolyl Oligopeptidase Inhibitors in Rat Models of Amnesia.
    Zolotov NN; Schepetkin IA; Voronina TA; Pozdnev VF; Khlebnikov AI; Krylova IV; Quinn MT
    Front Chem; 2021; 9():780958. PubMed ID: 35004610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low molecular weight inhibitors of Prolyl Oligopeptidase: a review of compounds patented from 2003 to 2010.
    López A; Tarragó T; Giralt E
    Expert Opin Ther Pat; 2011 Jul; 21(7):1023-44. PubMed ID: 21539473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolyl oligopeptidase: a potential target for the treatment of cognitive disorders.
    Männisto PT; Venäläinen J; Jalkanen A; García-Horsman JA
    Drug News Perspect; 2007 Jun; 20(5):293-305. PubMed ID: 17878957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolyl oligopeptidase and its role in the organism: attention to the most promising and clinically relevant inhibitors.
    Babkova K; Korabecny J; Soukup O; Nepovimova E; Jun D; Kuca K
    Future Med Chem; 2017 Jun; 9(10):1015-1038. PubMed ID: 28632451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect of prolyl oligopeptidase inhibition on spatial memory in young but not in old scopolamine-treated rats.
    Jalkanen AJ; Puttonen KA; Venäläinen JI; Sinervä V; Mannila A; Ruotsalainen S; Jarho EM; Wallén EA; Männistö PT
    Basic Clin Pharmacol Toxicol; 2007 Feb; 100(2):132-8. PubMed ID: 17244263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific inhibitors for prolyl endopeptidase and their anti-amnesic effect.
    Yoshimoto T; Kado K; Matsubara F; Koriyama N; Kaneto H; Tsura D
    J Pharmacobiodyn; 1987 Dec; 10(12):730-5. PubMed ID: 3330562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzimidazolium salts as small, nonpeptidic and BBB-permeable human prolyl oligopeptidase inhibitors.
    Tarragó T; Masdeu C; Gómez E; Isambert N; Lavilla R; Giralt E
    ChemMedChem; 2008 Oct; 3(10):1558-65. PubMed ID: 18792035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner.
    Myöhänen TT; Tenorio-Laranga J; Jokinen B; Vázquez-Sánchez R; Moreno-Baylach MJ; García-Horsman JA; Männistö PT
    Br J Pharmacol; 2011 Aug; 163(8):1666-78. PubMed ID: 21133893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of novel chemical scaffolds targeting prolyl oligopeptidase for neurological therapeutics.
    Kumar R; Parameswaran S; Bavi R; Baek A; Son M; Rampogu S; Park C; Lee G; Zeb A; Parate S; Rana RM; Lee KW
    J Mol Graph Model; 2019 May; 88():92-103. PubMed ID: 30665156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of novel (123)I-labeled 4-(4-iodophenyl)butanoyl-L-prolyl-(2S)-pyrrolidines for imaging prolyl oligopeptidase in vivo.
    Kallinen A; Todorov B; Kallionpää R; Bäck S; Sarparanta M; Raki M; García-Horsman JA; Bergström KA; Wallén EA; Männistö PT; Airaksinen AJ
    Eur J Med Chem; 2014 May; 79():436-45. PubMed ID: 24763264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of immunoreactive prolyl oligopeptidase in human and rat brain.
    Myöhänen TT; Venäläinen JI; Tupala E; Garcia-Horsman JA; Miettinen R; Männistö PT
    Neurochem Res; 2007 Aug; 32(8):1365-74. PubMed ID: 17401647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of prolyl oligopeptidase by Fmoc-aminoacylpyrrolidine-2-nitriles.
    Li J; Wilk E; Wilk S
    J Neurochem; 1996 May; 66(5):2105-12. PubMed ID: 8780042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding kinetics and duration of in vivo action of novel prolyl oligopeptidase inhibitors.
    Venäläinen JI; Garcia-Horsman JA; Forsberg MM; Jalkanen A; Wallén EA; Jarho EM; Christiaans JA; Gynther J; Männistö PT
    Biochem Pharmacol; 2006 Feb; 71(5):683-92. PubMed ID: 16405869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dicarboxylic acid azacycle l-prolyl-pyrrolidine amides as prolyl oligopeptidase inhibitors and three-dimensional quantitative structure-activity relationship of the enzyme-inhibitor interactions.
    Jarho EM; Wallén EA; Christiaans JA; Forsberg MM; Venäläinen JI; Männistö PT; Gynther J; Poso A
    J Med Chem; 2005 Jul; 48(15):4772-82. PubMed ID: 16033257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Issues about the physiological functions of prolyl oligopeptidase based on its discordant spatial association with substrates and inconsistencies among mRNA, protein levels, and enzymatic activity.
    Myöhänen TT; García-Horsman JA; Tenorio-Laranga J; Männistö PT
    J Histochem Cytochem; 2009 Sep; 57(9):831-48. PubMed ID: 19687473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative effect of the prolyl endopeptidase inhibitors, benzyloxycarbonyl-prolyl-prolinal and benzyloxycarbonyl-methionyl-cyanopyrrolidine, on the acute exudative inflammation and visceral pain in mice].
    Ivanova EA; Zolotov NN; Voronina TA
    Biomed Khim; 2020 Sep; 66(5):423-426. PubMed ID: 33140738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baicalin, a prodrug able to reach the CNS, is a prolyl oligopeptidase inhibitor.
    Tarragó T; Kichik N; Claasen B; Prades R; Teixidó M; Giralt E
    Bioorg Med Chem; 2008 Aug; 16(15):7516-24. PubMed ID: 18650094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Covalent Inhibition of Prolyl Oligopeptidase (POP): Discovery of Sulfonylfluoride Peptidomimetics.
    Guardiola S; Prades R; Mendieta L; Brouwer AJ; Streefkerk J; Nevola L; Tarragó T; Liskamp RMJ; Giralt E
    Cell Chem Biol; 2018 Aug; 25(8):1031-1037.e4. PubMed ID: 29779956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computer-Aided Drug Discovery Identifies Alkaloid Inhibitors of Parkinson's Disease Associated Protein, Prolyl Oligopeptidase.
    Kulkarni AM; Rampogu S; Lee KW
    Evid Based Complement Alternat Med; 2021; 2021():6687572. PubMed ID: 33897801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of diverse psychopharmacological substances on the activity of brain prolyl oligopeptidase.
    Peltonen I; Männistö PT
    Basic Clin Pharmacol Toxicol; 2011 Jan; 108(1):46-54. PubMed ID: 20825390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.